Tempest Therapeutics Inc. – Filings and Transcripts

NASDAQ: TPST
Share price (3/23/26): $1.84
Market cap (3/23/26): $9.066 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024 – amended

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Initial registration of new securities

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

News Filter

Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Announces Interim Results From Ongoing REDEEM-1 Trial of TPST-2003, Preparing for Potential U.S. Registrational Study in 2026

Investor Presentation

Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Change of Control, Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Material Modification to Rights of Security Holders, Change in Directors, Officers or Compensation, Shareholder Vote Results

Proxies Filter

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC